Shu; Youheng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shu; Youheng.The latest application filed is for "quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use".

Company Profile

0.11.13

Shu; Youheng - Blue Bell PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,663,506 - Bungard , et al. May 30, 2	2017-05-30
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,636,337 - Bungard , et al. May 2, 2	2017-05-02
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160159744 - Bungard; Christopher James ; et al.	2016-06-09
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160158217 - Bungard; Christopher James ; et al.	2016-06-09
N-linked lactam M1 receptor positive allosteric mogulators Grant 9,206,200 - Kuduk , et al. December 8, 2	2015-12-08
N-linked Lactam M1 Receptor Positive Allosteric Modulators App 20150065498 - Kuduk; Scott D. ; et al.	2015-03-05
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20140309227 - Bungard; Christopher James ; et al.	2014-10-16
Isoindolone M1 receptor positive allosteric modulators Grant 8,697,690 - Beshore , et al. April 15, 2	2014-04-15
Heterocycle phenyl amide T-type calcium channel antagonists Grant 8,637,513 - Barrow , et al. January 28, 2	2014-01-28
Isoindolone M1 Receptor Positive Allosteric Modulators App 20130109686 - Beshore; Douglas C. ; et al.	2013-05-02
Pyridyl Amide T-Type Calcium Channel Antagonists App 20110112064 - Barrow; James C. ; et al.	2011-05-12
Heterocycle Phenyl Amide T-type Calcium Channel Antagonists App 20100261724 - Barrow; James C. ; et al.	2010-10-14
Heterocycle Amide T-type Calcium Channel Antagonists App 20100249176 - Barrow; James C. ; et al.	2010-09-30
Cannabinoid receptor ligands Grant 7,645,774 - Friary , et al. January 12, 2	2010-01-12
Pyridyl Amide T-Type Calcium Channel Antagonists App 20090275550 - Barrow; James C. ; et al.	2009-11-05
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,566,718 - Wong , et al. July 28, 2	2009-07-28
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20060276480 - Wong; Michael K. C. ; et al.	2006-12-07
Cannabinoid receptor ligands Grant 7,071,213 - Friary , et al. July 4, 2	2006-07-04
Cannabinoid receptor ligands App 20040010013 - Friary, Richard J. ; et al.	2004-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.